Japanese order as next milestone for Single Use Support

Only shortly after entering the Indian market, Single Use Support has now expanded its Asian business areas once again: One of the biggest biopharmaceutical companies in Japan has now ordered products for leveraging large scale development of monoclonal antibodies.

Double Helix International Inc., as local partner in Japan, has realized the spectacular deal and the resulting achievement of another milestone for Single Use Support. By providing innovative technological solutions for filling and draining liquid medicines into single-use bags, the Austrian Biotech supplier Single Use Support emphasizes its international ambitions and pursues its goal of becoming a global player in the handling and logistics of highly valuable drug substances.